PATENT CLAIM ANALYSIS

Application Number: 15972655
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "472000"]

Abstract:
A pharmaceutical composition comprises at least one integrase inhibitor or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug and at least one antiretroviral or anti-HIV agent or its salt, solvate, complex, hydrate, isomer, ester, tautomer, anhydrate, enantiomer, polymorph or prodrug.

Claim (Index 17):
A process comprising utilizing the pharmaceutical composition according to  claim 1 , in the manufacture of a medicament for the prevention, treatment or prophylaxis of diseases caused by retroviruses.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 2.28571
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14429651', '14744915', '15624166', '15280801', '13004533']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7306563659040315
- 35 USC 102 Novelty (BERT): 0.5843849660404349
- Combined Prediction Score: 0.7160292259176719
- Mean Citation Score: 313.305146
- Max Citation Score: 475.60028
- Similarity Product: 463.3317253375625

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test